RecruitingPhase 4NCT05080569
Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment
LUMO Study: Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH
Sponsor
UMC Utrecht
Enrollment
1,008 participants
Start Date
Mar 1, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
The LUMO study is a multicenter, randomized controlled trial that evaluates the effectivity of luteal phase support in MOH/IUI treatment.
Eligibility
Sex: FEMALEMin Age: 18 Years
Inclusion Criteria8
- Couples starting IUI with Mild Ovarian HyperStimulation (MOH), with the intend to receive this treatment for at least six months.
- Diagnosis of unexplained (primary or secondary) infertility
- Hunault \<30% (or \>30%, after an expectant management period of at least 6 additional months).
- Females aged \>18 years with regular menstrual cycle.
- Total mobile sperm count (VCM) \>10 million.
- Exclusion cirteria:
- Cycle irregularities
- Male factor infertility
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGProgesterone Vaginal Product
3dd200mg
DRUGPlacebo
3dd1 vaginal capsule
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05080569
Related Trials
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
NCT062589021 location
Longitudinal Study of Gene Expression in the Human Placenta During First-trimester and Full-term Pregnancy at the Single Cell Level
NCT064274081 location
Adaptation of an Intervention Addressing Barriers to PrEP Use Among Pregnant Women in Zimbabwe
NCT062261551 location
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
NCT0729355911 locations
Towards Optimal Fertility, Fathering and Fatherhood studY
NCT062932351 location